HMPV is spreading in China but there's no need to worry
Respiratory illness is common in winter
![Two people holding poster warning of HMPV](https://cdn.mos.cms.futurecdn.net/ifZSPStcr6BKeLMxJA2DfD-1280-80.jpg)
Cases of the human metapneumovirus (HMPV) are on the rise in China, causing global concern. The respiratory virus is not new, but much of the public was previously unaware of its existence. Experts say the disease is likely not going to be the next pandemic and the worry is a result of heightened wariness for respiratory illness in a post-Covid world.
What is HMPV?
HMPV is a respiratory virus that regularly circulates during cold and flu season. It is spread through coughing, sneezing and coming into contact with contaminated surfaces. It presents as common cold symptoms including cough, fever, shortness of breath and congestion. While not deadly, in some instances, cases can be more severe, especially in young children and the immunocompromised. They could "develop more severe disease where the lungs are affected, with wheezing, breathlessness and symptoms of croup," said the BBC. This could require hospitalization.
While China seems to have a spike in cases, its "reported levels of respiratory infections were along usual and expected rates, said a news briefing by the World Health Organization (WHO). The rise of HMPV is likely because "China underwent one of the world's most restrictive and prolonged lockdowns in response to Covid, reducing people's exposure to other viruses such as HMPV," said The Washington Post. "That created a situation where people became more susceptible during a surge," leading to "unusual cases even in young and middle-aged adults." The surge also aligns with low temperatures expected to last until March.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Should people be worried?
Experts aren't sounding the alarm just yet about HMPV. "It's not a new virus," Margaret Harris, a spokesperson for the WHO, said in the news briefing. "It was first identified in 2001. It's been in the human population for a long time. It is a common virus that circulates in winter and spring." The disease has been circulating similar to the flu, RSV and walking pneumonia. "How many times do you get sick in the winter and you have no idea what you've got?" said Jennifer Nuzzo, a professor of epidemiology and director of the Pandemic Center at the Brown University School of Public Health, to the Post. "It's a virus you'll get. You'll probably get it multiple times in your life."
HMPV is also not expected to be a global pandemic like Covid-19. The disease is well-studied and has been known for a long time. "There is broad population-level immunity to this virus globally; there was none, for Covid," said The New York Times. "A severe HMPV season can strain hospital capacity — particularly pediatric wards — but does not overwhelm medical centers." While there is no vaccine or antiviral for the disease, in most people it tends to pass on its own.
In general, "there's just this tendency post-Covid to treat every infectious disease anything as an emergency when it's not," Amesh Adalja, an infectious diseases physician and senior scholar at the Johns Hopkins Center for Health Security, said to the Post. However, while it is not expected to grow into a deadly pandemic, HMPV "should not be ignored," said virologist Connor Bamford in an opinion for The I Paper. "We must continue research into these viruses so we can better deploy interventions like vaccines, antivirals and preventative measures for known and unknown viruses in the future."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
5 meritorious cartoons about the war on DEI
Cartoons Artists take on self-evident truths, recent history, and more
By The Week US Published
-
Bucatini alla zozzona recipe
The Week Recommends Classic Roman dish is 'slurpy, fun and absolutely heavenly'
By The Week UK Published
-
The UK 'spy cops' scandal, explained
The Explainer Undercover police targeting activist groups conducted intrusive surveillance, with some even embarking on relationships under assumed identities
By The Week UK Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
IVM is a better treatment than IVF for some people
The Explainer A less painful, less costly option for treating infertility emerges
By Theara Coleman, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published
-
Is this the end of cigarettes?
Today's Big Question An FDA rule targets nicotine addiction
By Joel Mathis, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Kidney stones are affecting children far more than they once did
Under the radar Salt may be to blame
By Devika Rao, The Week US Published